We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Editorial: Acute Promyelocytic Leukemia — Towards A Chemotherapy-Free Approach to Cure in All Patients.
- Authors
Gill, Harinder; Kwong, Yok-Lam; Ravandi, Farhad
- Abstract
Acute promyelocytic leukemia, chemotherapy-free, arsenic trioxide, tetraarsenic tetrasulfide, oral arsenic trioxide With regard to the therapeutic application of intravenous arsenic trioxide, Russell and Dillon summarize the United Kingdom's NCRI AML17 experience using the attenuated arsenic trioxide regimen in newly diagnosed APL. Keywords: acute promyelocytic leukemia; arsenic trioxide; chemotherapy-free; tetraarsenic tetrasulfide; oral arsenic trioxide EN acute promyelocytic leukemia arsenic trioxide chemotherapy-free tetraarsenic tetrasulfide oral arsenic trioxide 1 3 3 01/24/22 20220120 NES 220120 Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML) characterized by t(15;17)(q24;21) and the fusion gene I PML-RARA i .
- Subjects
ACUTE promyelocytic leukemia; HEMATOPOIETIC stem cell transplantation
- Publication
Frontiers in Oncology, 2022, Vol 11, p1
- ISSN
2234-943X
- Publication type
Article
- DOI
10.3389/fonc.2021.831308